Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ...
Protein sequencing makes it possible to differentiate variants in long COVID patients, potentially leading to new insights and treatment strategies for the disease. 1 In this article, a method ...
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based ...
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (QSI) (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company ...
The most exclusive club in omics has admitted only genomics and transcriptomics, the beneficiaries of single-molecule sequencing technologies that are so powerful they enable highly refined ...
Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...
Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results